References
- Mamoulakis D, Galanakis E, Dionyssopoulou E, Evangeliou A, Sbyrakis S. Carnitine deficiency in children and adolescents with type 1 diabetes. Journal of Diabetes and Its Complications, 2004;18(5), 271-274.
- Gülçin İ. Antioxidant and antiradical activities of L-carnitine. Life Sciences, 2006;78(8), 803-811
- Deniz G. Karnitin: sentez, metabolizma, fonksiyon ve iskemik kalpte terapötik önemi. Turkiye Klinikleri Journal of Medical Sciences, 1999;19(1), 5-62.
- Yavuz H, Kurtoğlu F. Biyokimyasal özellikleri ile L-karnitin. Journal of The Faculty of Veterinary Medicine, İstanbul University, 2012;38(2), 207-218.
- Mahmood M D, Al-Youzbaki W B, Aziz B N. Effects of L-carnitine on glycemic control, serum insulin and c-peptide level in alloxan-induced diabetic rabbit. Pharmacie Globale, 2014;5(2), 1.
- Tamamoğullari N, Siliğ Y, İçağasioğlu S, Atalay A. Carnitine deficiency in diabetes mellitus complications. Journal of Diabetes and Its Complications, 1999;13(5), 251-253.
- Sütken E, Uslu S, Aral E, Özdemir F, Alataş, Ö. Diabetik sıçanlarda L-karnitin, n-asetil-β-d-glukozaminidaz düzeyleri ve erken diabetik nefropatide plazma fibronektinin rolü. Anadolu University Journal of Science And Technology, 2009;10:2
- Korkmaz S, Yıldız G, Kılıçlı F, Yılmaz A, Aydın H, İçağasıoğlu S, Candan F. Düşük L-karnitin düzeyleri: Tip 2 diyabetes mellitus olgularında noktürnal kan basıncı değişikliklerinin bir nedeni olabilir mi?. The Anatolian Journal of Cardiology, 2011;1, 57-63.
- Ringseis R, Keller J, Eder K. Role of carnitine in the regulation of glucose homeostasis and insulin sensitivity: evidence from in vivo and in vitro studies with carnitine supplementation and carnitine deficiency. European Journal of Nutrition, 2012;51(1), 1-18.
- Yoon K H, Lee J. H, Kim J W, Cho J H, Choi Y H, Ko S H, Son H Y. Epidemic obesity and type 2 diabetes in Asia. The Lancet, 2006;368(9548), 1681-1688.
- Reda E, D’iddio S, Nicolai R, Benatti P, Calvani M. The carnitine system and body composition. Acta diabetologica, 2003;40(1), s106-s113.
- Peluso G, Mingrone G, Barbarisi A, Petillo O, Greco A V, Indiveri C, Calvani M. Decreased skeletal muscle carnitine translocase impairs utilization of fatty acids in insulin-resistant human muscle. Front Biosci, 2002;7, A109-A116.
- Mingrone G, Greco A V, Capristo E, Benedetti G, Giancaterini A, Gaetano A D, Gasbarrini G. L-carnitine improves glucose disposal in type 2 diabetic patients. Journal of the American College of Nutrition, 1999;18(1), 77-82.
- Derosa G, Maffioli P, Ferrari I, D’Angelo A, Fogari E, Palumbo I, Randazzo S, Cicero A F. Orlistat and L-carnitine compared to orlistat alone on insulin resistance in obese diabetic patients. Endocrine Journal, 2009;57(9), 777-786.
- Sirtori C R, Calabresi L, Ferrara S, Pazzucconi F, Bondioli A, Baldassarre D, Birreci A, Koverech A. L-carnitine reduces plasma lipoprotein (a) levels in patients with hyper Lp (a). Nutrition, Metabolism and Cardiovascular Diseases: 2000;10(5), 247-251.
- Malaguarnera M, Vacante M, Avitabile T, Malaguarnera M, Cammalleri L, Motta M. L-Carnitine supplementation reduces oxidized LDL cholesterol in patients with diabetes. The American Journal of Clinical Nutrition, 2009;89(1), 71-76.
- Gonzalez-Ortiz M, Hernandez-Gonzalez S O, Hernandez-Salazar E, Martinez-Abundis E. Effect of oral L-carnitine administration on insulin sensitivity and lipid profile in type 2 diabetes mellitus patients. Annals of Nutrition and Metabolism, 2008;52(4), 335-338.
- Bebis Nutrition Data Base Software Data Base. The German Food Code and Nutrient Data Base (BLS II.3, 1999) with additions from USDA-sr and other sources, Istanbul, Turkey. 2004
- Wallace T M, Levy J C, Matthews D R. Use and abuse of HOMA modeling. Diabetes Care, 2004;27(6), 1487-1495.
- Bouchouirab F Z, Fortin M, Noll C, Dubé J, Carpentier A C. Plasma palmitoyl-carnitine (AC16: 0) is a marker of increased postprandial nonesterified incomplete fatty acid oxidation rate in adults with type 2 diabetes. Canadian journal of diabetes, 2018;42(4), 382-388.
- Bene J, Hadzsiev K, Melegh B. Role of carnitine and its derivatives in the development and management of type 2 diabetes. Nutrition & diabetes, 2018;8(1), 1-10.
- De Palo E, Gatti R, Sicolo N, Padovan D, Vettor R, Federspil G. Plasma and urine free L-carnitine in human diabetes mellitus. Acta Diabetologica, 1981;18(1), 91-95.
- American Diabetes Association (ADA). Standards of medical care in diabetes-2016, Diabetes Care, 2016;39(1).
- Köseoğlu Ö. Tip 2 diyabetik bireylerde beslenme eğitiminin diyabet durumu ve beslenme alışkanlıklarına etkisi. Yayımlanmamış Yüksek Lisans Tezi, Başkent Üniversitesi Sağlık Bilimleri Enstitüsü, Ankara. 2015.
- Wolfram T, Ismail-Beigi F. Efficacy of high-fiber diets in the management of type 2 diabetes mellitus. Endocrine Practice, 2010;17(1), 132-142.
- Marshall J A, Bessesen D H, Hamman R F. High saturated fat and low starch and fibre are associated with hyperinsulinaemia in a non-diabetic population: the San Luis Valley Diabetes Study. Diabetologia, 1997;40(4), 430-438
- Salmeron J, Hu F B, Manson J E, Stampfer M J, Colditz G A, Rimm E B, Willett W C. Dietary fat intake and risk of type 2 diabetes in women. The American Journal of Clinical Nutrition, 2001;73(6), 1019-1026
- Özpak Akkuş Ö. Comparison of serum vitamin D, calcium and magnesium levels with nutritional habits among type 2 diabetic and nondiabetic ındividuals. Başkent University, Institute of Health Sciences, Nutrition and Dietetic Program, PhD Thesis, Ankara, 2015.
- El-Badry A M, Graf R, Clavien P A. Omega 3–Omega 6: What is right for the liver?. Journal of Hepatology, 2007;47(5), 718-725.
- Reuter S E, Evans A M. Carnitine and acylcarnitines. Clinical Pharmacokinetics, 2012;51(9), 553-572
- Derosa G, Maffioli P, Ferrari I, D’Angelo A. Fogari E, Palumbo I, Cicero A F. Orlistat and L-carnitine compared to orlistat alone on insulin resistance in obese diabetic patients. Endocrine Journal, 2010;57(9), 777-786.
- Müller D M, Seim H, Kiess W, Richter T. Effects of oral L-carnitine supplementation on in vivo long-chain fatty acid oxidation in healthy adults. Metabolism-Clinical and Experimental, 2002;51(1), 1389-1391.
- Mun E G, Soh J R, Cha Y S. L-carnitine reduces obesity caused by high-fat diet in C57BL/6J mice. Food Science and Biotechnology, 2007;16(2), 58-63.
- Ramazani M, Qujeq D, Moazezi Z. Assessing the levels of L-carnitine and total antioxidant capacity in adults with newly diagnosed and long-standing type 2 diabetes. Canadian journal of diabetes, 2019;43(1), 46-50.
- Talenezhad N, Mohammadi M, Ramezani-Jolfaie N, Mozaffari-Khosravi H, Salehi-Abargouei A. Effects of l-carnitine supplementation on weight loss and body composition: A systematic review and meta-analysis of 37 randomized controlled clinical trials with dose-response analysis. Clinical nutrition ESPEN. 2020